Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ingestible Shape-Shifting Capsule Prompts Weight Loss

By HospiMedica International staff writers
Posted on 05 Nov 2018
A novel self-administered device induces weight loss and improves glycemic control in overweight and obese patients.

The Epitomee Medical (Caesarea; Israel) Epitomee capsule is a drug-free, ingestible capsule that contains a biodegradable shape-shifting gel scaffold, which mechanically resists peristaltic waves as they progress through the stomach wall after eating. More...
Triggered by stomach pH level, the mechanical resistance stimulates mechanoreceptors that create a sense of satiety, stalling gastric emptying. The gel scaffold acts on the stomach tissue for a period of several hours before it dissolves, thus avoiding stomach adaptation.

The treatment, which is administered twice daily, is intended for overweight or slightly obese persons with a body mass index (BMI) of 25-35 kg/m2 who seeks effective and safe assistance in weight loss. In a recent phase 2 study involving 52 patients, the average excess body weight loss was -21.8%, average BMI declined from 33 to 31, and waist circumference was reduced by 4.41 cm. Moreover, 80% of those patients who were hypertensive became normalized at week 12, and in 53% of pre-diabetic patients, fasting glucose was reduced from 104 to 92 and HbA1C% was reduced from 6.03 to 5.6.

“This self-use concept of the Epitomee capsule could represent a new direction in the way we treat overweight and obesity and could be very encouraging to many of my patients,” said Professor Haim Shirin, MD, director of the Institute of Gastroenterology, Liver Diseases, and Nutrition at Assaf Harofeh Medical Center (Beer Yaakov; Israel), who presented the study at the IsraeLIVE Endoscopy International conference, held during October 2018 in Haifa (Israel). “We were happy to see that there were no serious treatment-related adverse events and that the treatment was well tolerated.”

“Our solution is unique, and the only one that can actually be scaled up to treat billions of people who can benefit from it. Our device can deliver a range of benefits that impact health, wellness and quality of life, from weight loss and glycemic control to body shaping and circumference reduction. We are now working on making it available to the relevant patients in the market,” said Dan Hashimshony, MD, CEO of Epitomee. “Thanks to this work we can now go further in our investigations and complete our advanced phase 2. This will bring the Capsule closer to people who seek a safe and simple clinical weight loss solution.”

Peristalsis is a radially symmetrical contraction and relaxation of muscles that propagate in a wave down a muscular tube, in an anterograde fashion. In much of the gastrointestinal (GI) tract, smooth muscle contracts in sequence to produce a peristaltic wave, which forces a bolus of food along it. Peristaltic movement is initiated by circular smooth muscles contracting behind the chewed material to prevent it from moving back into the mouth, followed by a contraction of longitudinal smooth muscles, which pushes the digested food forward.

Related Links:
Epitomee Medical


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.